A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney Recipients
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
Assessment of the safety and the efficacy of a tacrolimus modified release (MR4) based
immunosuppressive regimen in stable kidney transplant subjects converted on a 1:1 (mg:mg)
basis from a Prograf® based immunosuppressive regimen.